Navigation Links
Optimer Pharmaceuticals Announces Key Additions to Management Team
Date:1/10/2011

SAN DIEGO, Jan. 10, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced the appointment of Linda Amper, Ph.D., as Senior Vice President of Human Resources, Hemal Shah as Senior Vice President of Health, Economics & Outcomes Research (HEOR), and John Womelsdorf, Ph.D., as Vice President of Business Development. These key positions will strengthen the management team as the Company prepares to become a commercial organization and prepares for the potential launch of its lead product candidate, fidaxomicin.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"These additions to our management team are an important step as we continue preparing for the planned commercialization of fidaxomicin," said Pedro Lichtinger, Optimer's President and CEO. "With the potential marketing approval of fidaxomicin in 2011, the expansion of our management team will help support and manage the anticipated growth at the Company, leverage the health economic benefit of fidaxomicin, and maximize business development and licensing opportunities."

Dr. Amper, with more than 20 years of experience in human resources, joins Optimer from OSI Pharmaceuticals (now Astellas Pharma) where she served as Senior Vice President, Human Resources for the last nine years. During her tenure at OSI, Dr. Amper transitioned the company from a research entity into a fully integrated commercial organization. Prior to joining OSI, she served at the New York Blood Center for 23 years where she held several key positions including her final position as Executive Director and Vice President of Long Island Blood Services, a division of the New York Blood Center.  Immediately prior to that position, Dr. Amper served as Vice President, Human Resources for the New York Blood Center.  Dr. Ampe
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent
2. Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection
3. Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
4. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
5. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
6. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
7. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
8. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
9. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015  For many businesses and industries just ... the case, having the right management software can be ... better than software solutions company TraxStar Technologies , ... the company announced the release of the newest version ... "QATrax ...
(Date:4/1/2015)... , April 1, 2015  The U.S. Food ... Sense4Baby™ wireless maternal/fetal monitoring system ... by pregnant patients to self-administer non-stress tests (NST). ... the FDA for use accompanied by medical professionals. ... European Commission in 2013 for self-administration, including the ...
(Date:4/1/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... medical paper has been published describing the positive ... with severe dry eye.  The results met key ... stated that statistically significant differences in both signs ... at various time points throughout the study.  Of ...
Breaking Medicine Technology:TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
... Md., Dec. 19, 2011 Medical imaging has revolutionized healthcare ... injury and disease. Modern equipment and protocols ensure that ... possible amounts of radiation, while still providing accurate results ... imaging and any medical procedure must be balanced with ...
... CAMBRIDGE, Mass., Dec. 19, 2011 At universities, ... ethics review boards tasked with overseeing the protection ... to improve the quality of reviews and research ... tremendous obligation from federal regulation and face intense pressure from ...
Cached Medicine Technology:AAPM Cautions that Patients Should Not Forgo Essential Medical Imaging 2IRBNet Announces 4th Annual IRBNet Ethics in Human Research Protection Award 2IRBNet Announces 4th Annual IRBNet Ethics in Human Research Protection Award 3IRBNet Announces 4th Annual IRBNet Ethics in Human Research Protection Award 4
(Date:4/1/2015)... (PRWEB) April 01, 2015 Tempaper has ... a new virtual giving campaign that will raise critical ... people fighting muscle disease across the United States. , ... MDA through Tempaperdesigns.com will automatically receive free ... bring strength and urgently needed progress to children and ...
(Date:4/1/2015)... Like a mosaic slowly gaining definition and becoming clear, ... causes of rosacea. April has been designated as Rosacea ... educate the public on the warning signs of this ... more than 16 million Americans. , The NRS ... patient-funded research grants program, awarding $1.4 million to date ...
(Date:4/1/2015)... IQ Formulations , one of the most highly ... the U.S., today is commending GNC for taking steps to ... its herbal supplements.* GNC vowed that its new processes will ... of labeling on its products. , In response to ... CEO Jay Cohen said: , “In a lightly-regulated industry ...
(Date:4/1/2015)... April 01, 2015 Health Advocate™, Inc., ... a subsidiary of West Corporation, today launched its new ... http://blog.healthadvocate.com and through the Health Advocate member website, ... get, and stay, healthy. , “We’re pleased to introduce ... the public,” said Martin Rosen, Executive Vice President, Health ...
(Date:4/1/2015)... 01, 2015 When annoying or concerning ... days or weeks for an appointment with a dermatologist ... next day appointments haven’t been possible within dermatology. However, ... offices have noticed demand for this level of service ... how important relief or answers to dermatological issues are ...
Breaking Medicine News(10 mins):Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2
... The prevalence of obesity and overweight in the ... diseases related to obesity raises serious implications for the ... issue of The American Journal of Gastroenterology ... colorectal cancer and gastroesophageal reflux disease, or GERD. , ...
... September 18,Seabrook House, a nationally recognized drug and ... Family Center, open house,from 10:00 am until noon. ... out,the 42,000-square-foot center and learn about the services ... exciting event gives outsiders an inside look at ...
... enables more wide-spread ... authentication for network access, DALLAS, Aug. 19 ... was,leveraging two-factor authentication via hardware tokens in order to,protect patient ... cost-prohibitive to deploy to a wider audience and,cumbersome for the ...
... Aug. 19 Employee Vita, a Chandler,Arizona-based vitamin ... new nutritional supplement targeted toward,nurses. The web-based vitamin ... offer,supplements that address the health needs of people ... those in other occupations," said,Brett Waslefsky, president of ...
... Afid Therapeutics, Inc.,announced today that it had completed successful ... efficacy of its new "traceless",anticoagulant, which is meant to ... of the in vitro studies were carried out by ... drug, which is used,beyond the reach of chemical synthesis ...
... Directions International Magazine Identify ... as Technology Leaders, MILFORD, Mass., Aug. 19 ... SYNAPT(TM) High Definition,MS(TM) (HDMS(TM)) System was recognized by Frost ... and Strategic Directions International,s,Instrument Business Outlook (IBO) selected the ...
Cached Medicine News:Health News:Obesity raises risks of serious digestive health concerns 2Health News:Seabrook House Welcomes Visitors to MatriArk Family Center 2Health News:Entrust IdentityGuard Enables Georgia-based Hospital Network to Deploy Strong Authentication for Remote Access 2Health News:Entrust IdentityGuard Enables Georgia-based Hospital Network to Deploy Strong Authentication for Remote Access 3Health News:New Vitamin Targets Needs of Nurses 2Health News:Afid Therapeutics Inc.'s New Anticoagulant Heparin Replacement Passes in Vivo Test 2Health News:Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts 2Health News:Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts 3Health News:Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts 4
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
A system for the removal and filtration of laser and surgical smoke....
The FreedomAire Surgical Helmet System is a lightweight, comfortable helmut system with superior air flow, and a removable motor module that lifts off for easy cleaning....
...
Medicine Products: